Reduction of mHTT aggregates in HD mouse models after AAV-CYP46A1 delivery is a consequence of the restoration of the mevalonate pathway of cholesterol synthesis by CYP46A1 [36, 37]. The gene discussed is CYP46A1; the disease is Huntington disease.